Discovery of the first potent and selective αvβ5 integrin inhibitor based on an amide-containing core
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of the first potent and selective αvβ5 integrin inhibitor based on an amide-containing core
Authors
Keywords
Integrins, avb5, Selective, Homology
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 208, Issue -, Pages 112719
Publisher
Elsevier BV
Online
2020-08-26
DOI
10.1016/j.ejmech.2020.112719
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Facile synthesis of 7-alkyl-1,2,3,4-tetrahydro-1,8-naphthyridines as arginine mimetics using a Horner–Wadsworth–Emmons-based approach
- (2020) Rhys A Lippa et al. Beilstein Journal of Organic Chemistry
- Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide
- (2019) Florian Reichart et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of an Orally Bioavailable Pan αv Integrin Inhibitor for Idiopathic Pulmonary Fibrosis
- (2019) Niall A. Anderson et al. JOURNAL OF MEDICINAL CHEMISTRY
- From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands
- (2018) Francesco Saverio Di Leva et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- An αv-RGD Integrin Inhibitor Toolbox: Drug Discovery Insight, Challenges and Opportunities
- (2018) Richard J. D. Hatley et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Discovery of (S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αvβ6 Integrin Inhibitor for the Inhaled Treatment of Idiopathic Pulmonary Fibrosis
- (2018) Panayiotis A. Procopiou et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins
- (2017) Tobias G. Kapp et al. Scientific Reports
- Integrin-based therapeutics: biological basis, clinical use and new drugs
- (2016) Klaus Ley et al. NATURE REVIEWS DRUG DISCOVERY
- Synthesis and determination of absolute configuration of a non-peptidic αvβ6 integrin antagonist for the treatment of idiopathic pulmonary fibrosis
- (2016) Niall A. Anderson et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Dissociation Constants (pKa) of Tertiary and Cyclic Amines: Structural and Temperature Dependences
- (2014) Aravind V. Rayer et al. JOURNAL OF CHEMICAL AND ENGINEERING DATA
- Structural determinants of integrin β-subunit specificity for latent TGF-β
- (2014) Xianchi Dong et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents
- (2014) James Adams et al. ACS Medicinal Chemistry Letters
- Effective Treatment of Mouse Sepsis With an Inhibitory Antibody Targeting Integrin αvβ5*
- (2013) George Su et al. CRITICAL CARE MEDICINE
- Target validation using chemical probes
- (2013) Mark E Bunnage et al. Nature Chemical Biology
- Absence of Integrin αvβ3 Enhances Vascular Leak in Mice by Inhibiting Endothelial Cortical Actin Formation
- (2011) George Su et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A General Strategy for the Perfluoroalkylation of Arenes and Arylbromides by Using Arylboronate Esters and [(phen)CuRF]
- (2011) Nichole D. Litvinas et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Integrin v 5-Mediated TGF- Activation by Airway Smooth Muscle Cells in Asthma
- (2011) A. L. Tatler et al. JOURNAL OF IMMUNOLOGY
- Conformational Control of Integrin-Subtype Selectivity in isoDGR Peptide Motifs: A Biological Switch
- (2010) Andreas O. Frank et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started